Fraunhofer Institute for Toxicology and Experimental MedicineCurrently, one in four deaths is caused by cancer – mainly as a result of metastatic disease spread. The focus of this Fraunhofer ITEM division in Regensburg, therefore, is on the development of diagnostic tests to enable detection of disseminated cancer cells early in the disease and prediction of the response to therapy of metastatic progenitor cells. Since the currently available therapies are effective only in one in four cancer patients, we aim to develop novel targeted systemic treatment options.
Read more about our research and development exptertise.
